Biblio

Ellingson HM, Vanderah TW.  2020.  Potential therapeutic treatments of cancer-induced bone pain.. Curr Opin Support Palliat Care. 14(2):107-111.

Ronaldson PT, Davis TP.  2020.  Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.. J Cereb Blood Flow Metab. 40(1_suppl):S6-S24.

Wang Y, Hernandez G, Mack WJ, Schneider LS, Yin F, Brinton RD.  2020.  Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.. Menopause. 27(1):57-65.

Lochhead JJ, Yang J, Ronaldson PT, Davis TP.  2020.  Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders.. Front Physiol. 11:914.

Williams EI, Betterton RD, Davis TP, Ronaldson PT.  2020.  Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke.. Pharmaceutics. 12(2)

Thompson AL, Largent-Milnes TM, Vanderah TW.  2019.  Animal Models for the Study of Bone-Derived Pain.. Methods Mol Biol. 1914:391-407.

Renault YJG, Lynch R, Marelli E, Sharma SV, Pubill-Ulldemolins C, Sharp JA, Cartmell C, Cárdenas P, Goss RJM.  2019.  Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions. Chemical Communications.

Renault YJG, Lynch R, Marelli E, Sharma SV, Pubill-Ulldemolins C, Sharp JA, Cartmell C, Cárdenas P, Goss RJM.  2019.  Buchwald Hartwig diversification of unprotected halotryptophans, halotryptophan containing tripeptides and the natural product barettin in aqueous conditions.. Chem Commun (Camb). 55(91):13653-13656.

Moutal A, Luo S, Largent-Milnes TM, Vanderah TW, Khanna R.  2019.  Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain.. Neurobiol Pain. 5

Qi G, Mi Y, Yin F.  2019.  Cellular Specificity and Inter-cellular Coordination in the Brain Bioenergetic System: Implications for Aging and Neurodegeneration.. Front Physiol. 10:1531.

Khanna R, Patwardhan A, Yang X, Li W, Cai S, Ji Y, Chew LA, Dorame A, Bellampalli SS, Schmoll RW et al..  2019.  Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light.. J Pain. 20(11):1293-1306.

, Vanderah TW, Largent-Milnes TM.  2019.  Migraine, A Review of Basic, Clinical, Translational Approaches to New Treatment. ARCH Women Health Care. 2(6):1-5.

Bacon ER, Mishra A, Wang Y, Desai MK, Yin F, Brinton RDiaz.  2019.  Neuroendocrine aging precedes perimenopause and is regulated by DNA methylation.. Neurobiol Aging. 74:213-224.

Hay M, Polt R, Heien ML, Vanderah TW, Largent-Milnes TM, Rodgers K, Falk T, Bartlett MJ, Doyle KP, Konhilas JP.  2019.  A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.. J Pharmacol Exp Ther. 369(1):9-25.

Chen Z, Doyle TM, Luongo L, Largent-Milnes TM, Giancotti LAntonio, Kolar G, Squillace S, Boccella S, Walker JK, Pendleton A et al..  2019.  Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain.. Proc Natl Acad Sci U S A. 116(21):10557-10562.

Abdullahi W, Tripathi D, Ronaldson PT.  2018.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.. Am J Physiol Cell Physiol. 315(3):C343-C356.

Pandit V, Khan M, Zakaria ERasheid, Largent-Milnes TM, Hamidi M, O'Keeffe T, Vanderah TW, Joseph B.  2018.  Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury.. J Trauma Acute Care Surg. 85(1):48-53.

Edwards KA, Havelin JJ, McIntosh MI, Ciccone HA, Pangilinan K, Imbert I, Largent-Milnes TM, King T, Vanderah TW, Streicher JM.  2018.  A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain.. J Pain. 19(6):612-625.

Cottier KE, Galloway EA, Calabrese EC, Tome ME, Liktor-Busa E, Kim J, Davis TP, Vanderah TW, Largent-Milnes TM.  2018.  Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.. eNeuro. 5(4)

Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW.  2018.  Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.. Pain. 159(9):1814-1823.

Watts GS, Youens-Clark K, Slepian MJ, Wolk DM, Oshiro MM, Metzger GS, Dhingra D, Cranmer LD, Hurwitz BL.  2017.  16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria.. J Appl Microbiol.

Starnowska J, Costante R, Guillemyn K, Popiolek-Barczyk K, Chung NN, Lemieux C, Keresztes A, Van Duppen J, Mollica A, Streicher J et al..  2017.  Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.. ACS Chem Neurosci.

Pan CC, Shah N, Kumar S, Wheeler SE, Cinti J, Hoyt DG, Beattie CE, An M, Mythreye K, L Rakotondraibe H et al..  2017.  Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy.. Oncotarget. 8(8):12675-12685.

Nelson MA, Lochhead JD, Maguire GA.  2017.  Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder.. Ann Clin Psychiatry. 29(3):205-206.

Moutal A, Dustrude ET, Largent-Milnes TM, Vanderah TW, Khanna M, Khanna R.  2017.  Blocking CRMP2 SUMOylation reverses neuropathic pain.. Mol Psychiatry.